BR0001515A - Composições de espuma estáveis - Google Patents
Composições de espuma estáveisInfo
- Publication number
- BR0001515A BR0001515A BR0001515-6A BR0001515A BR0001515A BR 0001515 A BR0001515 A BR 0001515A BR 0001515 A BR0001515 A BR 0001515A BR 0001515 A BR0001515 A BR 0001515A
- Authority
- BR
- Brazil
- Prior art keywords
- stable foam
- foam compositions
- substrate
- presented
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/30—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by mixing gases into liquid compositions or plastisols, e.g. frothing with air
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- General Preparation And Processing Of Foods (AREA)
- Jellies, Jams, And Syrups (AREA)
- Formation And Processing Of Food Products (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Patente de Invenção: "COMPOSIçõES DE ESPUMA ESTáVEIS". A presente invenção proporciona um substrato adequado que se dissolve rapidamente e se quebra imediatamente para a adição de agentes farmacêuticos para administração oral. Um método para produção de um substrato é também apresentado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/282,859 US6090401A (en) | 1999-03-31 | 1999-03-31 | Stable foam composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0001515A true BR0001515A (pt) | 2002-01-08 |
Family
ID=23083433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0001515-6A BR0001515A (pt) | 1999-03-31 | 2000-03-31 | Composições de espuma estáveis |
Country Status (9)
Country | Link |
---|---|
US (1) | US6090401A (pt) |
EP (1) | EP1040823A3 (pt) |
JP (1) | JP2000325028A (pt) |
KR (1) | KR20010006903A (pt) |
CN (1) | CN1275335A (pt) |
AR (1) | AR023228A1 (pt) |
BR (1) | BR0001515A (pt) |
CA (1) | CA2303570A1 (pt) |
MX (1) | MXPA00003182A (pt) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK19412001A3 (sk) | 1999-07-02 | 2002-08-06 | The Procter & Gamble Company | Dávkovací systém na dodávanie látky ústnej hygieny do dutiny ústnej a spôsob dávkovania |
DE10032456A1 (de) * | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
GB2366780A (en) * | 2000-07-07 | 2002-03-20 | Bioprogress Tech Int Inc | Foam capsules |
US20020119196A1 (en) * | 2000-12-21 | 2002-08-29 | Narendra Parikh | Texture masked particles containing an active ingredient |
US6800668B1 (en) | 2001-01-19 | 2004-10-05 | Intellipharmaceutics Corp. | Syntactic deformable foam compositions and methods for making |
BR0207930A (pt) * | 2001-03-05 | 2004-03-02 | Ortho Mcneil Pharm Inc | Composições farmacêuticas lìquidas com sabor mascarado |
EP1438024B1 (en) * | 2001-09-04 | 2007-06-13 | Dow Global Technologies Inc. | Process for dispersing a fluid in solid particles |
BR0212951A (pt) * | 2001-09-28 | 2004-10-26 | Mcneil Ppc Inc | Formas de dosagens compósitas |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US6998480B2 (en) | 2002-03-08 | 2006-02-14 | Tate & Lyle Public Limited Company | Process for improving sucralose purity and yield |
US7049435B2 (en) | 2002-03-08 | 2006-05-23 | Tate & Lyle Public Limited Company | Extractive methods for purifying sucralose |
CA2482448C (en) * | 2002-04-11 | 2014-07-08 | Medimmune Vaccines, Inc. | Preservation of bioactive materials by freeze dried foam |
US8524200B2 (en) | 2002-09-11 | 2013-09-03 | The Procter & Gamble Company | Tooth whitening products |
US20040131743A1 (en) * | 2003-01-06 | 2004-07-08 | Diran Ajao | Quickly dissolving aerated confections and methods of preparation |
US20040151756A1 (en) * | 2003-02-04 | 2004-08-05 | Richards Anthony P. | Edible low density high surface area drug vehicle, method of manufacturing low density high surface area drug vehicle |
WO2004087084A1 (en) * | 2003-03-26 | 2004-10-14 | The Procter & Gamble Company | Rapidly dissolving edible film compositions with cellulose film forming polymers |
EP1605908A2 (en) * | 2003-03-26 | 2005-12-21 | The Procter & Gamble Company | Rapidly dissolving edible film compositions with improved film strength and stability |
CA2529984C (en) | 2003-06-26 | 2012-09-25 | Isa Odidi | Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors |
US8105642B2 (en) * | 2003-07-15 | 2012-01-31 | General Mills Ip Holdings Ii, Llc | Soft dried marshmallow and method of preparation |
ES2343890T3 (es) * | 2003-09-08 | 2010-08-12 | Fmc Biopolymer As | Espuma gelificada a base de biopolimero. |
US20050186271A1 (en) * | 2004-02-24 | 2005-08-25 | Sheskey Paul J. | Process for dispersing a fluid in a mass of solid particles |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US8673352B2 (en) | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
US7300912B2 (en) * | 2005-08-10 | 2007-11-27 | Fiore Robert A | Foaming cleansing preparation and system comprising coated acid and base particles |
US20070077300A1 (en) * | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
ATE486593T1 (de) * | 2006-03-16 | 2010-11-15 | Novartis Ag | Feste dosierungsform mit einem wirkstoff mit unterdrücktem geschmack |
EP2007360B1 (en) | 2006-04-03 | 2014-11-26 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
US8436156B2 (en) * | 2008-01-04 | 2013-05-07 | Tate & Lyle Technology Limited | Method for the production of sucralose |
JP2011517445A (ja) * | 2008-03-20 | 2011-06-09 | テート アンド ライル テクノロジー リミテッド | 第三級アミド溶媒からの酸の除去 |
US8436157B2 (en) * | 2008-03-26 | 2013-05-07 | Tate & Lyle Technology Limited | Method for the production of sucralose |
US8497367B2 (en) * | 2008-04-03 | 2013-07-30 | Tate & Lyle Technology Limited | Sucralose purification process |
AR071134A1 (es) * | 2008-04-03 | 2010-05-26 | Tate & Lyle Technology Ltd | Cristalizacion de sucralosa a partir de chorros que contienen sucralosa |
US8212022B2 (en) * | 2008-04-03 | 2012-07-03 | Tate & Lyle Technology Limited | Effect of carbohydrate concentration on sucralose extraction efficiency |
WO2009124113A1 (en) * | 2008-04-03 | 2009-10-08 | Tate & Lyle Technology Ltd. | Extraction of less polar impurities from sucralose containing aqueous feed streams |
GB2469158B (en) | 2009-03-31 | 2011-09-28 | Peter J Seaberg | Base-assisted formation of tin-sucrose adducts |
GB2474310B (en) | 2009-10-12 | 2012-02-29 | Tate & Lyle Technology Ltd | Process for the production of sucrose-6-ester |
GB2474311B (en) * | 2009-10-12 | 2012-10-17 | Tate & Lyle Technology Ltd | Low temperature, single solvent process for the production of sucrose-6-ester |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
WO2012125297A1 (en) | 2011-03-01 | 2012-09-20 | The Procter & Gamble Company | Porous disintegratable solid substrate for personal health care applications |
GB201110520D0 (en) | 2011-05-10 | 2011-08-03 | Tate & Lyle Technology Ltd | Extraction of carboxylic acids with tin compounds |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
US20140255452A1 (en) | 2013-03-11 | 2014-09-11 | Niconovum Usa, Inc. | Method and apparatus for differentiating oral pouch products |
EP3063217A1 (en) * | 2013-11-27 | 2016-09-07 | Dow Global Technologies LLC | Low temperature process for producing dry cellulose ether based foams |
US20160184230A1 (en) * | 2014-04-30 | 2016-06-30 | Aron H. Blaesi | Melt-processed polymeric cellular dosage form |
CN105295116A (zh) * | 2015-11-10 | 2016-02-03 | 中国工程物理研究院激光聚变研究中心 | 一种低密度结冷胶泡沫材料及其制备方法 |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
WO2017147059A1 (en) | 2016-02-26 | 2017-08-31 | The Hershey Company | Solid foam products and methods of making the same |
CN109310646A (zh) | 2016-05-05 | 2019-02-05 | 阿奎斯蒂弗医疗股份有限公司 | 增强递送的肾上腺素组合物 |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
DE102017112527B4 (de) * | 2017-06-07 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Schnell zerfallende Schaumwafer mit hohem Flächengewicht |
CN107821948B (zh) * | 2017-10-18 | 2021-06-15 | 河南工业大学 | 老年人高能量高保质期的馒头以及制备方法 |
BR112020025604A2 (pt) | 2018-06-15 | 2021-03-23 | R.J. Reynolds Tobacco Company | purificação de nicotina |
MX2020013731A (es) * | 2018-06-20 | 2021-02-26 | Axcella Health Inc | Composiciones para terapia y salud que contienen aminoacidos con sabor amargo. |
JP7454619B1 (ja) | 2022-09-20 | 2024-03-22 | クラシエ株式会社 | 粉末組成物、薬剤の苦味マスキング用組合せ食品、及び薬剤の苦味マスキング方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6054322B2 (ja) * | 1977-09-30 | 1985-11-29 | 株式会社林原生物化学研究所 | 成形物の製法 |
US4251561A (en) * | 1979-06-04 | 1981-02-17 | General Mills, Inc. | Low-moisture, frangible aerated confections and method of preparation |
US4401508A (en) * | 1982-10-27 | 1983-08-30 | Rca Corporation | Method for removing insolubilized PVA from the surface of a body |
US4642903A (en) * | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
JPH0826346B2 (ja) * | 1986-07-10 | 1996-03-13 | 株式会社林原生物化学研究所 | 固状油溶性物質の製法 |
US4714620A (en) * | 1986-12-12 | 1987-12-22 | Warner-Lambert Company | Soft, sugarless aerated confectionery composition |
CH672996A5 (pt) * | 1987-06-26 | 1990-01-31 | Battelle Memorial Institute | |
US5079018A (en) * | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
US5453338A (en) * | 1992-03-31 | 1995-09-26 | Dai Nippon Printing Co., Ltd. | Hologram and method of and apparatus for producing the same |
US5489616A (en) * | 1990-06-07 | 1996-02-06 | Korea Research Institute Of Chemical Technology | Process for manufacturing phosphoric acid-type chelate resin as uranyl ion absorbents |
US5393528A (en) * | 1992-05-07 | 1995-02-28 | Staab; Robert J. | Dissolvable device for contraception or delivery of medication |
US5458884A (en) * | 1992-09-10 | 1995-10-17 | Britton; Peter | Bioerodible device for administering active ingredients |
US5352709A (en) * | 1993-01-29 | 1994-10-04 | International Technology Management Associates, Ltd. | Algal plastics |
US5342635A (en) * | 1993-05-12 | 1994-08-30 | General Mills, Inc. | Puffed edible foams and high intensity microwave method of preparation |
FR2706737B1 (pt) * | 1993-06-24 | 1995-08-25 | Roquette Freres | |
US5523106A (en) * | 1994-02-03 | 1996-06-04 | Nabisco, Inc. | Juice-based expanded snacks and process for preparing them |
GB9904629D0 (en) * | 1999-03-02 | 1999-04-21 | Danbiosyst Uk | Oral drug delivery system |
-
1999
- 1999-03-31 US US09/282,859 patent/US6090401A/en not_active Expired - Lifetime
-
2000
- 2000-03-22 JP JP2000080130A patent/JP2000325028A/ja active Pending
- 2000-03-29 KR KR1020000016096A patent/KR20010006903A/ko not_active Application Discontinuation
- 2000-03-30 CA CA002303570A patent/CA2303570A1/en not_active Abandoned
- 2000-03-30 MX MXPA00003182A patent/MXPA00003182A/es unknown
- 2000-03-30 EP EP00302639A patent/EP1040823A3/en not_active Withdrawn
- 2000-03-31 CN CN00105346.9A patent/CN1275335A/zh active Pending
- 2000-03-31 BR BR0001515-6A patent/BR0001515A/pt not_active IP Right Cessation
- 2000-03-31 AR ARP000101456A patent/AR023228A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1275335A (zh) | 2000-12-06 |
JP2000325028A (ja) | 2000-11-28 |
EP1040823A2 (en) | 2000-10-04 |
CA2303570A1 (en) | 2000-09-30 |
AR023228A1 (es) | 2002-09-04 |
EP1040823A3 (en) | 2000-12-20 |
US6090401A (en) | 2000-07-18 |
MXPA00003182A (es) | 2002-03-08 |
KR20010006903A (ko) | 2001-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0001515A (pt) | Composições de espuma estáveis | |
BRPI0408396A (pt) | pelìculas de dissolução rápida, consumìveis por via oral, contendo agentes farmaceuticamente ativos | |
BR9914251A (pt) | Formulações orais de liberação sustentada | |
FR2808685B1 (fr) | Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires | |
HRP20050781B1 (hr) | Metode i farmaceutske mješavine za pouzdano postizanje prihvatljivih razina testosterona u serumu | |
WO2002032376A3 (en) | Bile-acid conjugates for providing sustained systemic concentrations of drugs | |
BR9906920A (pt) | "tts contendo um antioxidante" | |
BR0015567A (pt) | Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos | |
PA8472301A1 (es) | Derivados de isotiazol utiles como agentes anticancerosos | |
BR0112054A (pt) | Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico | |
BR0215184A (pt) | composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada | |
DK0680326T3 (da) | Farmaceutisk formulering af nikotinafhængighed. | |
PA8529501A1 (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7." | |
BR0110129A (pt) | Composição farmacêutica | |
BR9909138A (pt) | Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda | |
BR0209283A (pt) | Método para a fabricação de uma composição farmacêutica de baixa dosagem tendo distribuição e potência de droga uniforme | |
BR0008509A (pt) | Composição farmacêutica oral estabilizada contendo iodeto e iodato e método | |
HUP0202862A2 (hu) | A loteprednol és antihisztaminok új kombinációját tartalmazó gyógyszerkészítmény | |
HUP0103781A2 (hu) | Megismerési képesség javítására szolgáló gyógyszerkészítmények, melyek atipikus antipszihotikus szer és acetilkolinészteráz inhibitor kombinációját tartalmazzák | |
BR9913135A (pt) | Formulação oral | |
CL2004001325A1 (es) | Una composicion farmaceutica de aerosol que comprende cilesonida solubilizada en un propelente hidrofluorocarbono y un co-solvente, de preferencia etanol, util como antiinflamatorio de las vias aereas. | |
AR035006A1 (es) | Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento. | |
BR0114395A (pt) | Composição farmacêutica para administração por suprimento via oral | |
ATE353224T1 (de) | Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz | |
HUP0300863A2 (hu) | N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 9/00 (2006.01) |